Jyothy Labs Limited

Jyothy Labs Limited

Jyothy Labs Limited has received an Excise Duty Order from the Commissionerate of Central Goods and Services Tax for a period from April 2016 to June 2017, resulting in a demand of Rs. 9.69 crore, including penalty and interest, due to a difference in interpretation of HSN classification of the product manufactured. The company does not foresee any material impact on its financials, operations, or other activities.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about the transcript of the earnings conference call for the quarter ended June 30, 2026. The company discussed the impact of crude oil and crude-linked derivatives volatility on input costs, packaging materials, and supply chain planning. They expect double-digit revenue growth for FY27, excluding the Pril business, and margin recovery over the coming quarters.

Jyothy Labs Limited

Jyothy Labs Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit after tax of ₹4,764 lakhs and a basic earnings per share of ₹1.30.

Jyothy Labs Limited

Jyothy Labs Limited has made available the audio recording of its conference call for analysts and investors to discuss its un-audited financial results for the quarter ended June 30, 2026.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange regarding the transfer of leasehold rights of its manufacturing facility in Jammu to Aikyam Flexipack Private Limited for a consideration of Rs. 9.93 crores.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about Investor Presentation, which includes a copy of the presentation on the Company’s performance for the quarter ended June 30, 2026. The presentation highlights the Company's revenue, gross margin, operating EBITDA, and PAT for the quarter. The Company's revenue from operation increased by 3% to ₹ 773 Crores, with a gross margin of 38.5% and operating EBITDA of 8.4%. The PAT for the quarter was ₹ 47.6 Crores, as against ₹ 96.8 Crores in the same period last year.

Jyothy Labs Limited

Jyothy Labs Limited announced its unaudited financial results for the quarter ended June 30, 2026, with revenue of ₹773 crore, registering 3.0% value growth year-on-year. The company reported an operating EBITDA margin of 8.4%, impacted by elevated commodity inflation and sustained volatility in crude-linked input costs. The demand environment remained mixed during the quarter, with rural markets exhibiting relative resilience while urban consumption continued to remain subdued.

Jyothy Labs Limited

Jyothy Labs Limited has released its Q1 FY27 investor presentation, highlighting a 3% revenue growth to ₹ 773 crores, with 8.1% value growth excluding Pril & Fa. Gross margin declined to 38.5% due to inflation in raw materials and packaging costs. Operating EBITDA margin decreased to 8.4% and PAT margin to 6.2%. The company has restructured its segment reporting into three categories: Fabric Care, Home Care, and Personal Care.

Jyothy Labs Limited

Jyothy Labs Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a limited review by the statutory auditors. The results show revenue from operations at ₹77,340 lakhs, other income at ₹1,765 lakhs, and total income at ₹79,105 lakhs.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a conference call for analysts/investors to discuss its un-audited financial results for the quarter ended June 30, 2026.

Jyothy Labs Limited

Jyothy Labs Limited has received an ESG rating of 'CRISIL ESG 62' under the Strong category from CRISIL ESG Rating & Analytics Limited for FY 2025-26.

Jyothy Labs Limited

Jyothy Labs Limited has submitted the Exchange a copy of the Scrutinizer's report of the 35th Annual General Meeting held on July 14, 2026, and informed the Exchange regarding voting results.

Jyothy Labs Limited

Jyothy Labs Limited has held its 35th Annual General Meeting (AGM) through video conferencing, with 64 members present representing 47.64% of the paid-up equity share capital. The meeting was chaired by Ms. M. R. Jyothy, Chairperson and Managing Director, and the requisite quorum was present.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialisation during the quarter ended June 30, 2026.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on June 30, 2026, to be attended by the company's representatives. The meeting will not disclose any unpublished price-sensitive information. The latest investor presentation is available on the company's website.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on June 30, 2026, with Edelweiss Mutual Fund, where no unpublished price sensitive information will be shared.

Jyothy Labs Limited

Jyothy Labs Limited has informed the Exchange about a scheduled investor/analyst meeting on June 29, 2026, to be attended by the company's representatives. The meeting is not expected to share any unpublished price-sensitive information.

Jyothy Labs Limited

Jyothy Labs Limited has closed its trading window for designated persons from July 1, 2026, until 48 hours after the release of its Q1 FY2026 financial results on June 30, 2026.

Jyothy Labs Limited

Jyothy Labs Limited announced that Henkel would not renew brand licenses for 'Pril' and 'Fa,' which expired on May 31, 2026. Consequently, Jyothy Labs ceased manufacturing, marketing, and distribution of these brands from June 1, 2026, after 15 years under license. The company has initiated arbitration at the Singapore International Arbitration Center to protect its contractual rights regarding the exit framework, including consideration for business momentum and goodwill created during the license period. Discussions for continuation or mutually acceptable resolution were unsuccessful.

Jyothy Labs Limited

Jyothy Labs Limited announced the dispatch of letters to its shareholders regarding the Annual Report for the fiscal year 2025-26. These letters provide a web-link to the comprehensive report and were specifically sent to shareholders whose email IDs are not registered with the company or its agents, ensuring widespread access. This action, in compliance with SEBI Listing Regulations, promotes transparency and provides investors with timely access to essential financial and operational information. The Annual Report is also readily available on the company's website.